Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipyrine and Benzocaine Otic Solution for Pain in Acute Otitis Media
NCT02037893Phase 2Completed
- Sponsor
- Currax Pharmaceuticals LLC
- Start
- Nov 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antipyrine, benzocaine in acute otitis media (AOM), sponsored by Currax Pharmaceuticals LLC. Started Nov 2013; status: completed.
02
Drugs
antipyrinebenzocaine
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT02037893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02037893.